Acute Kidney Injury (AKI): A Multifaceted Clinical Syndrome with Complex Diagnostic and Management Approach: An Overview of Pathogenesis, Prognosis, and Management
Kianoush KashaniDivision of Nephrology and Hypertension, Division of Pulmonary and Critical Care Medicine, and Department of Medicine, Mayo Clinic, Rochester, Minnesota
CollisterD, PannuN, YeF, JamesM, HemmelgarnB, ChuiB, Alberta Kidney Disease Network, et al.: Health care costs associated with AKI. Clin J Am Soc Nephrol12: 1733–1743, 2017PubMed
ZarbockA, KüllmarM, OstermannM, LuccheseG, BaigK, CennamoA, et al.: Prevention of cardiac surgery-associated acute kidney injury by implementing the KDIGO guidelines in high-risk patients identified by biomarkers: The PrevAKI-multicenter randomized controlled trial. Anesth Analg133: 292–302, 2021PubMed
GöczeI, JauchD, GötzM, KennedyP, JungB, ZemanF, et al.: Biomarker-guided intervention to prevent acute kidney injury after major surgery: The prospective randomized BigpAK study. Ann Surg267: 1013–1020, 2018PubMed
National Institute for Health and Care Excellence: Acute kidney injury: Prevention, detection and management, 2019. Available at: https://www.nice.org.uk/guidance/ng148. Accessed September 16, 2020
National Institute for Health and Care Excellence: Acute kidney injury: Prevention, detection and management, 2019. Available at: https://www.nice.org.uk/guidance/ng148. Accessed September 16, 2020)| false
FloegeJ, JayneDRW, SandersJ-SF, TesarV, BalkEM, GordonCE, et al.: Executive summary of the KDIGO 2024 clinical practice guideline for the management of ANCA-associated vasculitis. Kidney Int105: 447–449, 2024PubMed
FloegeJ, JayneDRW, SandersJ-SF, TesarV, BalkEM, GordonCE, : Executive summary of the KDIGO 2024 clinical practice guideline for the management of ANCA-associated vasculitis. Kidney Int 105: 447–449, 2024PubMed)| false
Connelly-SmithL, AlquistCR, AquiNA, HofmannJC, KlingelR, OnwuemeneOA, et al.: Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Writing Committee of the American Society for Apheresis: The ninth special issue. J Clin Apher38: 77–278, 2023PubMed
Connelly-SmithL, AlquistCR, AquiNA, HofmannJC, KlingelR, OnwuemeneOA, : Guidelines on the use of therapeutic apheresis in clinical practice - Evidence-based approach from the Writing Committee of the American Society for Apheresis: The ninth special issue. J Clin Apher 38: 77–278, 2023PubMed)| false
DaherEF, Silva JuniorGB, SantosSQ, R BezerraCC, DinizEJB, LimaRSA, et al.: Differences in community, hospital and intensive care unit-acquired acute kidney injury: Observational study in a nephrology service of a developing country. Clin Nephrol78: 449–455, 2012PubMed
DaherEF, Silva JuniorGB, SantosSQ, R BezerraCC, DinizEJB, LimaRSA, : Differences in community, hospital and intensive care unit-acquired acute kidney injury: Observational study in a nephrology service of a developing country. Clin Nephrol 78: 449–455, 2012PubMed)| false
MacedoE, HemmilaU, SharmaSK, Claure-Del GranadoR, MzinganjiraH, BurdmannEA, ISN 0by25 Trial Study Group, et al.: Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study. PLoS Med18: e1003408, 2021PubMed
MacedoE, HemmilaU, SharmaSK, Claure-Del GranadoR, MzinganjiraH, BurdmannEA, ISN 0by25 Trial Study Group, : Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study. PLoS Med 18: e1003408, 2021PubMed)| false
SelbyNM, CasulaA, LammingL, StovesJ, SamarasingheY, LewingtonAJ, et al.: An organizational-level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol30: 505–515, 2019PubMed
SelbyNM, CasulaA, LammingL, StovesJ, SamarasingheY, LewingtonAJ, : An organizational-level program of intervention for AKI: A pragmatic stepped wedge cluster randomized trial. J Am Soc Nephrol 30: 505–515, 2019PubMed)| false
BianchiNA, StavartLL, AltarelliM, KelevinaT, FaouziM, SchneiderAG, et al.: Association of oliguria with acute kidney injury diagnosis, severity assessment, and mortality among patients with critical illness. JAMA Netw Open4: e2133094, 2021PubMed
BianchiNA, StavartLL, AltarelliM, KelevinaT, FaouziM, SchneiderAG, : Association of oliguria with acute kidney injury diagnosis, severity assessment, and mortality among patients with critical illness. JAMA Netw Open 4: e2133094, 2021PubMed)| false
PickupL, LoutradisC, LawJP, ArnoldJJ, DasguptaI, SarafidisP, et al.: The effect of admission and pre-admission serum creatinine as baseline to assess incidence and outcomes of acute kidney injury in acute medical admissions. Nephrol Dial Transplant37: 148–158, 2021PubMed
PickupL, LoutradisC, LawJP, ArnoldJJ, DasguptaI, SarafidisP, : The effect of admission and pre-admission serum creatinine as baseline to assess incidence and outcomes of acute kidney injury in acute medical admissions. Nephrol Dial Transplant 37: 148–158, 2021PubMed)| false
KashaniK, ShaoM, LiG, WilliamsAW, RuleAD, KremersWK, et al.: No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study. Kidney Int92: 721–728, 2017PubMed
KashaniK, ShaoM, LiG, WilliamsAW, RuleAD, KremersWK, : No increase in the incidence of acute kidney injury in a population-based annual temporal trends epidemiology study. Kidney Int 92: 721–728, 2017PubMed)| false
LiT, WuB, LiL, BianA, NiJ, LiuK, et al.: Automated electronic alert for the care and outcomes of adults with acute kidney injury: A randomized clinical trial. JAMA Netw Open7: e2351710, 2024PubMed
LiT, WuB, LiL, BianA, NiJ, LiuK, : Automated electronic alert for the care and outcomes of adults with acute kidney injury: A randomized clinical trial. JAMA Netw Open 7: e2351710, 2024PubMed)| false
HalmyL, RiedelJ, ZemanF, TegeB, LinderV, GnewuchC, et al.: Renal recovery after the implementation of an electronic alert and biomarker-guided kidney-protection strategy following major surgery. J Clin Med10: 5122, 2021PubMed
HalmyL, RiedelJ, ZemanF, TegeB, LinderV, GnewuchC, : Renal recovery after the implementation of an electronic alert and biomarker-guided kidney-protection strategy following major surgery. J Clin Med 10: 5122, 2021PubMed)| false
JamesMT, LeveyAS, TonelliM, TanZ, BarryR, PannuN, et al.: Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system. JAMA Netw Open2: e191795, 2019PubMed
JamesMT, LeveyAS, TonelliM, TanZ, BarryR, PannuN, : Incidence and prognosis of acute kidney diseases and disorders using an integrated approach to laboratory measurements in a universal health care system. JAMA Netw Open 2: e191795, 2019PubMed)| false
ChuR, LiC, WangS, ZouW, LiuG, YangL, et al.: Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease. Clin J Am Soc Nephrol9: 1175–1182, 2014PubMed
KoynerJL, MackeyRH, RosenthalNA, CarabuenaLA, KampfJP, EcheverriJ, et al.: Health care resource utilization and costs of persistent severe acute kidney injury (PS-AKI) among hospitalized stage 2/3 AKI patients. Kidney3604: 316–325, 2023PubMed
KoynerJL, MackeyRH, RosenthalNA, CarabuenaLA, KampfJP, EcheverriJ, : Health care resource utilization and costs of persistent severe acute kidney injury (PS-AKI) among hospitalized stage 2/3 AKI patients. Kidney360 4: 316–325, 2023PubMed)| false
KashaniK, OmerT, ShawAD: The intensivist’s perspective of shock, volume management, and hemodynamic monitoring. Clin J Am Soc Nephrol17: 706–716, 2022PubMed
MianoTA, HennessyS, YangW, DunnTG, WeismanAR, OniyideO, et al.: Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: A prospective cohort study. Intensive Care Med48: 1144–1155, 2022PubMed
MianoTA, HennessyS, YangW, DunnTG, WeismanAR, OniyideO, : Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: A prospective cohort study. Intensive Care Med 48: 1144–1155, 2022PubMed)| false
QianET, CaseyJD, WrightA, WangL, ShotwellMS, SiemannJK, Vanderbilt Center for Learning Healthcare and the Pragmatic Critical Care Research Group, et al.: Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: The ACORN randomized clinical trial. JAMA330: 1557–1567, 2023PubMed
QianET, CaseyJD, WrightA, WangL, ShotwellMS, SiemannJK, Vanderbilt Center for Learning Healthcare and the Pragmatic Critical Care Research Group, : Cefepime vs piperacillin-tazobactam in adults hospitalized with acute infection: The ACORN randomized clinical trial. JAMA 330: 1557–1567, 2023PubMed)| false
PragaM, SevillanoA, AuñónP, GonzálezE: Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant30: 1472–1479, 2015PubMed
PragaM, SevillanoA, AuñónP, GonzálezE: Changes in the aetiology, clinical presentation and management of acute interstitial nephritis, an increasingly common cause of acute kidney injury. Nephrol Dial Transplant 30: 1472–1479, 2015PubMed)| false
EshkiM, AllanoreL, MusetteP, MilpiedB, GrangeA, GuillaumeJ-C, et al.: Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. Arch Dermatol145: 67–72, 2009PubMed
EshkiM, AllanoreL, MusetteP, MilpiedB, GrangeA, GuillaumeJ-C, : Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: A cause of unpredictable multiorgan failure. Arch Dermatol 145: 67–72, 2009PubMed)| false
Dagnon da SilvaM, et al.: Renal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A systematic review of 71 cases. J Clin Med12: 4576, 2023PubMed
Dagnon da SilvaM, : Renal manifestations of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: A systematic review of 71 cases. J Clin Med 12: 4576, 2023PubMed)| false
KashaniKB, AwdishuL, BagshawSM, BarretoEF, Claure-Del GranadoR, EvansBJ, et al.: Digital health and acute kidney injury: Consensus report of the 27th Acute Disease Quality Initiative workgroup. Nat Rev Nephrol19: 807–818, 2023PubMed
MalhotraR, KashaniKB, MacedoE, KimJ, BouchardJ, WynnS, et al.: A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant32: 814–822, 2017PubMed
MalhotraR, KashaniKB, MacedoE, KimJ, BouchardJ, WynnS, : A risk prediction score for acute kidney injury in the intensive care unit. Nephrol Dial Transplant 32: 814–822, 2017PubMed)| false
LiuX, BarretoEF, DongY, LiuC, GaoX, TootooniMS, et al.: Discrepancy between perceptions and acceptance of clinical decision support systems: Implementation of artificial intelligence for vancomycin dosing. BMC Med Inform Decis Mak23: 157, 2023PubMed
LiuX, BarretoEF, DongY, LiuC, GaoX, TootooniMS, : Discrepancy between perceptions and acceptance of clinical decision support systems: Implementation of artificial intelligence for vancomycin dosing. BMC Med Inform Decis Mak 23: 157, 2023PubMed)| false
SjostromP, TidmanM, JonesI: Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest65: 111–124, 2005PubMed
SjostromP, TidmanM, JonesI: Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 65: 111–124, 2005PubMed)| false
SjostromP, TidmanM, JonesI: The shorter T1/2 of cystatin C explains the earlier change of its serum level compared to serum creatinine. Clin Nephrol62: 241–242, 2004PubMed
SjostromP, TidmanM, JonesI: The shorter T1/2 of cystatin C explains the earlier change of its serum level compared to serum creatinine. Clin Nephrol 62: 241–242, 2004PubMed)| false
MårtenssonJ, MartlingC-R, OldnerA, BellM: Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients. Nephrol Dial Transplant27: 576–581, 2012PubMed
MårtenssonJ, MartlingC-R, OldnerA, BellM: Impact of sepsis on levels of plasma cystatin C in AKI and non-AKI patients. Nephrol Dial Transplant 27: 576–581, 2012PubMed)| false
KnightEL, VerhaveJC, SpiegelmanD, HillegeHL, de ZeeuwD, CurhanGC, et al.: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int65: 1416–1421, 2004PubMed
KnightEL, VerhaveJC, SpiegelmanD, HillegeHL, de ZeeuwD, CurhanGC, : Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416–1421, 2004PubMed)| false
SotoK, CoelhoS, RodriguesB, MartinsH, FradeF, LopesS, et al.: Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol5: 1745–1754, 2010PubMed
SotoK, CoelhoS, RodriguesB, MartinsH, FradeF, LopesS, : Cystatin C as a marker of acute kidney injury in the emergency department. Clin J Am Soc Nephrol 5: 1745–1754, 2010PubMed)| false
CaironiP, LatiniR, StruckJ, HartmannO, BergmannA, BellatoV, ALBIOS Study Investigators, et al.: Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock. Clin Chem64: 1361–1369, 2018PubMed
CaironiP, LatiniR, StruckJ, HartmannO, BergmannA, BellatoV, ALBIOS Study Investigators, : Circulating proenkephalin, acute kidney injury, and its improvement in patients with severe sepsis or shock. Clin Chem 64: 1361–1369, 2018PubMed)| false
KimH, HurM, LeeS, MarinoR, MagriniL, CardelliP, GREAT Network, et al.: Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med37: 388–397, 2017PubMed
KimH, HurM, LeeS, MarinoR, MagriniL, CardelliP, GREAT Network, : Proenkephalin, neutrophil gelatinase-associated lipocalin, and estimated glomerular filtration rates in patients with sepsis. Ann Lab Med 37: 388–397, 2017PubMed)| false
HollingerA, WitteboleX, FrançoisB, PickkersP, AntonelliM, GayatE, et al.: Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) study. Kidney Int Rep3: 1424–1433, 2018PubMed
HollingerA, WitteboleX, FrançoisB, PickkersP, AntonelliM, GayatE, : Proenkephalin A 119-159 (Penkid) is an early biomarker of septic acute kidney injury: The Kidney in Sepsis and Septic Shock (Kid-SSS) study. Kidney Int Rep 3: 1424–1433, 2018PubMed)| false
DebreczenyMP, DorshowRB: Transdermal optical renal function monitoring in humans: Development, verification, and validation of a prototype device. J Biomed Opt23: 1–9, 2018PubMed
DebreczenyMP, DorshowRB: Transdermal optical renal function monitoring in humans: Development, verification, and validation of a prototype device. J Biomed Opt 23: 1–9, 2018PubMed)| false
KashaniK, Al-KhafajiA, ArdilesT, ArtigasA, BagshawSM, BellM, et al.: Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care17: R25, 2013PubMed
MeerschM, SchmidtC, HoffmeierA, Van AkenH, WempeC, GerssJ, et al.: Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med43: 1551–1561, 2017PubMed
MeerschM, SchmidtC, HoffmeierA, Van AkenH, WempeC, GerssJ, : Prevention of cardiac surgery-associated AKI by implementing the KDIGO guidelines in high risk patients identified by biomarkers: The PrevAKI randomized controlled trial. Intensive Care Med 43: 1551–1561, 2017PubMed)| false
MishraJ, DentC, TarabishiR, MitsnefesMM, MaQ, KellyC, et al.: Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet365: 1231–1238, 2005PubMed
KoynerJL, VaidyaVS, BennettMR, MaQ, WorcesterE, AkhterSA, et al.: Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol5: 2154–2165, 2010PubMed
KoynerJL, VaidyaVS, BennettMR, MaQ, WorcesterE, AkhterSA, : Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol 5: 2154–2165, 2010PubMed)| false
SchunkSJ, ZarbockA, MeerschM, KüllmarM, KellumJA, SchmitD, et al.: Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: An observational cohort study. Lancet394: 488–496, 2019PubMed
SchunkSJ, ZarbockA, MeerschM, KüllmarM, KellumJA, SchmitD, : Association between urinary dickkopf-3, acute kidney injury, and subsequent loss of kidney function in patients undergoing cardiac surgery: An observational cohort study. Lancet 394: 488–496, 2019PubMed)| false
HosteE, BihoracA, Al-KhafajiA, OrtegaLM, OstermannM, HaaseM, RUBY Investigators, et al.: Identification and validation of biomarkers of persistent acute kidney injury: The RUBY study. Intensive Care Med46: 943–953, 2020PubMed
HosteE, BihoracA, Al-KhafajiA, OrtegaLM, OstermannM, HaaseM, RUBY Investigators, : Identification and validation of biomarkers of persistent acute kidney injury: The RUBY study. Intensive Care Med 46: 943–953, 2020PubMed)| false
Murray PT, MehtaRL, ShawA, RoncoC, EndreZ, KellumJA, et al.: Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int85: 513–521, 2014PubMed
Murray PT, MehtaRL, ShawA, RoncoC, EndreZ, KellumJA, : Potential use of biomarkers in acute kidney injury: report and summary of recommendations from the 10th Acute Dialysis Quality Initiative consensus conference. Kidney Int 85: 513–521, 2014PubMed)| false
MolinariL, Del Rio-PertuzG, SmithA, LandsittelDP, SingbartlK, PalevskyPM, ProCESS and ProGReSS-AKI Investigators, et al.: Utility of biomarkers for sepsis-associated acute kidney injury staging. JAMA Netw Open5: e2212709, 2022PubMed
MolinariL, Del Rio-PertuzG, SmithA, LandsittelDP, SingbartlK, PalevskyPM, ProCESS and ProGReSS-AKI Investigators, : Utility of biomarkers for sepsis-associated acute kidney injury staging. JAMA Netw Open 5: e2212709, 2022PubMed)| false
PerazellaMA, CocaSG, KanbayM, BrewsterUC, ParikhCR: Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol3: 1615–1619, 2008PubMed
PerazellaMA, CocaSG, KanbayM, BrewsterUC, ParikhCR: Diagnostic value of urine microscopy for differential diagnosis of acute kidney injury in hospitalized patients. Clin J Am Soc Nephrol 3: 1615–1619, 2008PubMed)| false
VargheseV, RiveraMS, AlalwanAA, AlghamdiAM, GonzalezME, VelezJCQ, et al.: Diagnostic utility of serial microscopic examination of the urinary sediment in acute kidney injury. Kidney3602: 182–191, 2021PubMed
AbdelhafezM, NayfehT, AtiehA, AbuShammaO, BabaaB, BaniowdaM, et al.: Diagnostic performance of fractional excretion of sodium for the differential diagnosis of acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol17: 785–797, 2022PubMed
AbdelhafezM, NayfehT, AtiehA, AbuShammaO, BabaaB, BaniowdaM, : Diagnostic performance of fractional excretion of sodium for the differential diagnosis of acute kidney injury: A systematic review and meta-analysis. Clin J Am Soc Nephrol 17: 785–797, 2022PubMed)| false
AndreiS, BahrP-A, NguyenM, BouhemadB, GuinotP-G: Prevalence of systemic venous congestion assessed by Venous Excess Ultrasound Grading System (VExUS) and association with acute kidney injury in a general ICU cohort: A prospective multicentric study. Crit Care27: 224, 2023PubMed
AndreiS, BahrP-A, NguyenM, BouhemadB, GuinotP-G: Prevalence of systemic venous congestion assessed by Venous Excess Ultrasound Grading System (VExUS) and association with acute kidney injury in a general ICU cohort: A prospective multicentric study. Crit Care 27: 224, 2023PubMed)| false
Beaubien-SoulignyW, BenkreiraA, RobillardP, BouabdallaouiN, ChasséM, DesjardinsG, et al.: Alterations in portal vein flow and intrarenal venous flow are associated with acute kidney injury after cardiac surgery: A prospective observational cohort study. J Am Heart Assoc7: e009961, 2018PubMed
MoledinaDG, ObeidW, SmithRN, RosalesI, SiseME, MoeckelG, et al.: Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. J Clin Invest133: e168950, 2023PubMed
MoledinaDG, ObeidW, SmithRN, RosalesI, SiseME, MoeckelG, : Identification and validation of urinary CXCL9 as a biomarker for diagnosis of acute interstitial nephritis. J Clin Invest 133: e168950, 2023PubMed)| false
MuriithiAK, NasrSH, LeungN: Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol8: 1857–1862, 2013PubMed
MuriithiAK, NasrSH, LeungN: Utility of urine eosinophils in the diagnosis of acute interstitial nephritis. Clin J Am Soc Nephrol 8: 1857–1862, 2013PubMed)| false
de BoerIH, AlpersCE, AzelogluEU, BalisUGJ, BaraschJM, BarisoniL, Kidney Precision Medicine Project, et al.: Rationale and design of the Kidney Precision Medicine Project. Kidney Int99: 498–510, 2021PubMed
de BoerIH, AlpersCE, AzelogluEU, BalisUGJ, BaraschJM, BarisoniL, Kidney Precision Medicine Project, : Rationale and design of the Kidney Precision Medicine Project. Kidney Int 99: 498–510, 2021PubMed)| false
MeekersE, DauwJ, MartensP, DhontS, VerbruggeFH, NijstP, et al.: Renal function and decongestion with acetazolamide in acute decompensated heart failure: The ADVOR trial. Eur Heart J44: 3672–3682, 2023PubMed
MentzRJ, AnstromKJ, EisensteinEL, SappS, GreeneSJ, MorganS, TRANSFORM-HF Investigators, et al.: Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: The TRANSFORM-HF randomized clinical trial. JAMA329: 214–223, 2023PubMed
MentzRJ, AnstromKJ, EisensteinEL, SappS, GreeneSJ, MorganS, TRANSFORM-HF Investigators, : Effect of torsemide vs furosemide after discharge on all-cause mortality in patients hospitalized with heart failure: The TRANSFORM-HF randomized clinical trial. JAMA 329: 214–223, 2023PubMed)| false
PaternaS, FasulloS, ParrinelloG, CannizzaroS, BasileI, VitranoG, et al.: Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci342: 27–37, 2011PubMed
PaternaS, FasulloS, ParrinelloG, CannizzaroS, BasileI, VitranoG, : Short-term effects of hypertonic saline solution in acute heart failure and long-term effects of a moderate sodium restriction in patients with compensated heart failure with New York Heart Association class III (Class C) (SMAC-HF Study). Am J Med Sci 342: 27–37, 2011PubMed)| false
LiuC, PengZ, GaoX, GajicO, DongY, ProkopLJ, et al.: Simultaneous use of hypertonic saline and IV furosemide for fluid overload: A systematic review and meta-analysis. Crit Care Med49: e1163–e1175, 2021PubMed
LiuC, PengZ, GaoX, GajicO, DongY, ProkopLJ, : Simultaneous use of hypertonic saline and IV furosemide for fluid overload: A systematic review and meta-analysis. Crit Care Med 49: e1163–e1175, 2021PubMed)| false
WongF, PappasSC, CurryMP, ReddyKR, RubinRA, PoraykoMK, CONFIRM Study Investigators, et al.: Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med384: 818–828, 2021PubMed
WongF, PappasSC, CurryMP, ReddyKR, RubinRA, PoraykoMK, CONFIRM Study Investigators, : Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome. N Engl J Med 384: 818–828, 2021PubMed)| false
AroraV, MaiwallR, RajanV, JindalA, Muralikrishna ShasthryS, KumarG, et al.: Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology71: 600–610, 2020PubMed
AroraV, MaiwallR, RajanV, JindalA, Muralikrishna ShasthryS, KumarG, : Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure. Hepatology 71: 600–610, 2020PubMed)| false
JoslinJ, WilsonH, ZubliD, GaugeN, KinironsM, HopperA, et al.: Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clin Med (Lond)15: 431–436, 2015PubMed
JoslinJ, WilsonH, ZubliD, GaugeN, KinironsM, HopperA, : Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle. Clin Med (Lond) 15: 431–436, 2015PubMed)| false
JamesMT, HarBJ, TyrrellBD, FarisPD, TanZ, SpertusJA, et al.: Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography: A randomized clinical trial. JAMA328: 839–849, 2022PubMed
JamesMT, HarBJ, TyrrellBD, FarisPD, TanZ, SpertusJA, : Effect of clinical decision support with audit and feedback on prevention of acute kidney injury in patients undergoing coronary angiography: A randomized clinical trial. JAMA 328: 839–849, 2022PubMed)| false
MolinariL, HeskiaF, PeerapornratanaS, RoncoC, GuzziL, TobackS, Sapphire and Protocolized Care for Early Septic Shock (ProCESS) Investigators, et al.: Limiting acute kidney injury progression in sepsis: Study protocol and trial simulation. Crit Care Med49: 1706–1716, 2021PubMed
MolinariL, HeskiaF, PeerapornratanaS, RoncoC, GuzziL, TobackS, Sapphire and Protocolized Care for Early Septic Shock (ProCESS) Investigators, : Limiting acute kidney injury progression in sepsis: Study protocol and trial simulation. Crit Care Med 49: 1706–1716, 2021PubMed)| false
MathisMR, NaikBI, FreundlichRE, ShanksAM, HeungM, KimM, Multicenter Perioperative Outcomes Group Investigators, et al.: Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology132: 461–475, 2020PubMed
MathisMR, NaikBI, FreundlichRE, ShanksAM, HeungM, KimM, Multicenter Perioperative Outcomes Group Investigators, : Preoperative risk and the association between hypotension and postoperative acute kidney injury. Anesthesiology 132: 461–475, 2020PubMed)| false
ShapiroNI, DouglasIS, BrowerRG, BrownSM, ExlineMC, GindeAA, National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, et al.: Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med388: 499–510, 2023PubMed
ShapiroNI, DouglasIS, BrowerRG, BrownSM, ExlineMC, GindeAA, National Heart, Lung, and Blood Institute Prevention and Early Treatment of Acute Lung Injury Clinical Trials Network, : Early restrictive or liberal fluid management for sepsis-induced hypotension. N Engl J Med 388: 499–510, 2023PubMed)| false
MylesPS, BellomoR, CorcoranT, ForbesA, PeytonP, StoryD, Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group, et al.: Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med378: 2263–2274, 2018PubMed
MylesPS, BellomoR, CorcoranT, ForbesA, PeytonP, StoryD, Australian and New Zealand College of Anaesthetists Clinical Trials Network and the Australian and New Zealand Intensive Care Society Clinical Trials Group, : Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med 378: 2263–2274, 2018PubMed)| false
CalfeeCS, DelucchiK, ParsonsPE, ThompsonBT, WareLB, MatthayMA, NHLBI ARDS Network, et al.: Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials. Lancet Respir Med2: 611–620, 2014PubMed
CalfeeCS, DelucchiK, ParsonsPE, ThompsonBT, WareLB, MatthayMA, NHLBI ARDS Network, : Subphenotypes in acute respiratory distress syndrome: Latent class analysis of data from two randomised controlled trials. Lancet Respir Med 2: 611–620, 2014PubMed)| false
BhatrajuPK, ZelnickLR, HertingJ, KatzR, MikacenicC, KosamoS, et al.: Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med199: 863–872, 2019PubMed
BhatrajuPK, ZelnickLR, HertingJ, KatzR, MikacenicC, KosamoS, : Identification of acute kidney injury subphenotypes with differing molecular signatures and responses to vasopressin therapy. Am J Respir Crit Care Med 199: 863–872, 2019PubMed)| false
RussellJA, WalleyKR, SingerJ, GordonAC, HébertPC, CooperDJ, VASST Investigators, et al.: Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med358: 877–887, 2008PubMed
BhatrajuPK, PrinceDK, MansourS, IkizlerTA, SiewED, ChinchilliVM, et al.: Integrated analysis of blood and urine biomarkers to identify acute kidney injury subphenotypes and associations with long-term outcomes. Am J Kidney Dis82: 311–321.e1, 2023PubMed
SilverSA, AdhikariNK, BellCM, ChanCT, HarelZ, KitchluA, et al.: Nephrologist Follow-Up versus Usual Care after an Acute Kidney Injury Hospitalization (FUSION): A randomized controlled trial. Clin J Am Soc Nephrol16: 1005–1014, 2021PubMed
PickkersP, MehtaRL, MurrayPT, JoannidisM, MolitorisBA, KellumJA, STOP-AKI Investigators, et al.: Effect of human recombinant alkaline phosphatase on 7-day creatinine clearance in patients with sepsis-associated acute kidney injury: A randomized clinical trial. Jama320: 1998–2009, 2018PubMed
LazzareschiD, MehtaRL, DemberLM, BernholzJ, TuranA, SharmaA, et al.: Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: A report from the 2020 Kidney Disease Clinical Trialists meeting. Nephrol Dial Transplant38: 834–844, 2023PubMed
LazzareschiD, MehtaRL, DemberLM, BernholzJ, TuranA, SharmaA, : Overcoming barriers in the design and implementation of clinical trials for acute kidney injury: A report from the 2020 Kidney Disease Clinical Trialists meeting. Nephrol Dial Transplant 38: 834–844, 2023PubMed)| false
PickkersP, AngusDC, BassK, BellomoR, van den BergE, BernholzJ, REVIVAL investigators, et al.: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL). Intensive Care Med50: 68–78, 2024PubMed
PickkersP, AngusDC, BassK, BellomoR, van den BergE, BernholzJ, REVIVAL investigators, : Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL). Intensive Care Med 50: 68–78, 2024PubMed)| false
MoskowitzA, BergKM, GrossestreuerAV, BalajiL, LiuX, CocchiMN, et al.: Thiamine for Renal Protection in Septic Shock (TRPSS): A randomized, placebo-controlled, clinical trial. Am J Respir Crit Care Med208: 570–578, 2023PubMed
MoskowitzA, BergKM, GrossestreuerAV, BalajiL, LiuX, CocchiMN, : Thiamine for Renal Protection in Septic Shock (TRPSS): A randomized, placebo-controlled, clinical trial. Am J Respir Crit Care Med 208: 570–578, 2023PubMed)| false
OdutayoA, HladunewichM: Obstetric nephrology: Renal hemodynamic and metabolic physiology in normal pregnancy. Clin J Am Soc Nephrol7: 2073–2080, 2012PubMed
MehrabadiA, DahhouM, JosephKS, KramerMS: Investigation of a rise in obstetric acute renal failure in the United States, 1999-2011. Obstet Gynecol127: 899–906, 2016PubMed
MehrabadiA, DahhouM, JosephKS, KramerMS: Investigation of a rise in obstetric acute renal failure in the United States, 1999-2011. Obstet Gynecol 127: 899–906, 2016PubMed)| false
LiuY, MaX, ZhengJ, LiuX, YanT: Pregnancy outcomes in patients with acute kidney injury during pregnancy: A systematic review and meta-analysis. BMC Pregnancy Childbirth17: 235, 2017PubMed
TangrenJ, HladunewichMA: The kidney in pregnancy. In: National Kidney Foundation’s Primer on Kidney Diseases, edited by GilbertSJ, WeinerDE, Philadelphia, Elsevier, 2018, pp 444–454.e1
TangrenJ, HladunewichMA: The kidney in pregnancy. In: National Kidney Foundation’s Primer on Kidney Diseases, edited by GilbertSJ, WeinerDE, Philadelphia, Elsevier, 2018, pp 444–454.e1)| false
ZeislerH, LlurbaE, ChantraineF, VatishM, StaffAC, SennströmM, et al.: Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med374: 13–22, 2016PubMed
ZeislerH, LlurbaE, ChantraineF, VatishM, StaffAC, SennströmM, : Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia. N Engl J Med 374: 13–22, 2016PubMed)| false
MachadoS, FigueiredoN, BorgesA, São José PaisM, FreitasL, MouraP, et al.: Acute kidney injury in pregnancy: A clinical challenge. J Nephrol25: 19–30, 2012PubMed
IbdahJA, BennettMJ, RinaldoP, ZhaoY, GibsonB, SimsHF, et al.: A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med340: 1723–1731, 1999PubMed
IbdahJA, BennettMJ, RinaldoP, ZhaoY, GibsonB, SimsHF, : A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women. N Engl J Med 340: 1723–1731, 1999PubMed)| false
RuleAD, AmerH, CornellLD, TalerSJ, CosioFG, KremersWK, et al.: The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med152: 561–567, 2010PubMed
RuleAD, AmerH, CornellLD, TalerSJ, CosioFG, KremersWK, : The association between age and nephrosclerosis on renal biopsy among healthy adults. Ann Intern Med 152: 561–567, 2010PubMed)| false
FormicaM, PolitanoP, MarazziF, TamagnoneM, SerraI, MarengoM, et al.: Acute kidney injury and chronic kidney disease in the elderly and polypharmacy. Blood Purif46: 332–336, 2018PubMed